university website

Huijser, E. (Erika), C.G. van Helden-Meeuwsen (Cornelia), N. Groot (Noortje), I.L.A. Bodewes (Iris), Wahadat, M.J. (M. Javad), M.W.J. Schreurs (Marco), P.L.A. van Daele (Paul), V.A.S.H. Dalm (Virgil), J.A.M. van Laar (Jan), P.M. van Hagen (Martin), et al. M. Waris (Matti), S.S.M. Kamphuis (Sylvia) and M.A. Versnel (Marjan)

2019-07-01

MxA is a clinically applicable biomarker for type i interferon activation in systemic lupus erythematosus and systemic sclerosis

Publication

Publication

Rheumatology (United Kingdom) , Volume 58 - Issue 7 p. 1302- 1303

Additional Metadata
Persistent URL doi.org/10.1093/rheumatology/kez078, hdl.handle.net/1765/117935
Series VSNU Open Access deal
Journal Rheumatology (United Kingdom)
Organisation Department of Immunology
Citation
Huijser, E. (Erika), van Helden-Meeuwsen, C., Groot, N., Bodewes, I., Wahadat, M.J. (M. Javad), Schreurs, M., … Versnel, M. (2019). MxA is a clinically applicable biomarker for type i interferon activation in systemic lupus erythematosus and systemic sclerosis. Rheumatology (United Kingdom), 58(7), 1302–1303. doi:10.1093/rheumatology/kez078


User Publication Person Organisation Collection
Close